...
首页> 外文期刊>The Journal of biological chemistry >Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis
【24h】

Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis

机译:失调的D-Dopachrome互变异物酶,一种缺氧诱导因子依赖性基因,与肾肿瘤发​​生中的巨噬细胞迁移抑制因子配合

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Clear cell renal cell carcinomas (ccRCCs) are characterized by biallelic loss of the von Hippel-Lindau tumor suppressor and subsequent constitutive activation of the hypoxia-inducible factors, whose transcriptional programs dictate major phenotypic attributes of kidney tumors. We recently described a role for the macrophage migration inhibitory factor (MIF) in ccRCC as an autocrine-signaling molecule with elevated expression in tumor tissues and in the circulation of patients that has potent tumor cell survival effects. MIF is a pleiotropic cytokine implicated in a variety of diseases and cancers and is the target of both small molecule and antibody-based therapies currently in clinical trials. Recent work by others has described D-dopachrome tautomerase (DDT) as a functional homologue of MIF with a similar genomic structure and expression patterns. Thus, we sought to determine a role for DDT in renal cancer. We find that DDT expression mirrors MIF expression in ccRCC tumor sections with high correlation and that, mechanistically, DDT is a novel hypoxia-inducible gene and direct target of HIF1α and HIF2α. Functionally, DDT and MIF demonstrate a significant overlap in controlling cell survival, tumor formation, and tumor and endothelial cell migration. However, DDT inhibition consistently displayed more severe effects on most phenotypes. Accordingly, although dual inhibition of DDT and MIF demonstrated additive effects in vitro, DDT plays a dominant role in tumor growth in vivo. Together, our findings identify DDT as a functionally redundant but more potent cytokine to MIF in cancer and suggest that current attempts to inhibit MIF signaling may fail because of DDT compensation.
机译:透明细胞肾细胞癌(CCRCCs)的特征在于von Hippel-lindau肿瘤抑制剂的双曲氏损失和随后的缺氧诱导因子的组成型激活,其转录方案决定了肾脏肿瘤的主要表型属性。我们最近描述了CCRCC中的巨噬细胞迁移抑制因子(MIF)作为自分泌信号分子的作用,具有肿瘤组织中升高的表达,并且在具有有效的肿瘤细胞存活作用的患者的循环中。 MIF是一种含有各种疾病和癌症的含有肺炎细胞因子,并且是目前在临床试验中的小分子和基于抗体的疗法的靶标。其他人的最新工作已经描述了D-Dopachrome互变异物酶(DDT)作为MIF的功能同源物,具有类似的基因组结构和表达模式。因此,我们试图确定肾癌中DDT的作用。我们发现DDT表达镜在CCRCC肿瘤部分中的MIF表达具有高相关性,并且机械地,DDT是一种新的缺氧诱导基因和HIF1α和HIF2α的直接靶标。在功能上,DDT和MIF在控制细胞存活,肿瘤形成和肿瘤和内皮细胞迁移方面表现出显着的重叠。然而,DDT抑制一致地对大多数表型效果更严重。因此,尽管DDT和MIF的双重抑制证明了体外添加剂效应,但DDT在体内肿瘤生长中起显性作用。我们的研究结果将DDT鉴定为MIF在癌症中的功能冗余但更有效的细胞因子,并表明目前由于DDT补偿而抑制MIF信号的尝试可能失效。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号